Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Wasserburg
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Stockholm
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Holmes Chapel
        • Ashton
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

LEARN

Sharing our knowledge

Access to our latest white papers, case studies, posters, webinars and videos.

Topic
Type

Video

Presentation at ICSE 2019 in Frankfurt

Video

Presentation at ICSE 2019 in Frankfurt

Poster

Recipharm and Oncopeptides: Successful Collaboration in the Development of Melflufen, a Peptidase-Potentiated Alkylating Agent in Clinical Trials

Case study

Developing a stability indicating method for the analysis of a complex combination drug product

Fact sheet

Recipharm Analytical Solutions™

Fact sheet

Extractables & leachables testing

Fact sheet

Fixed dose combinations - for improved patient compliance

Fact sheet

Oral modified release

White paper

API scale-up and transfer to drug product development: a best practice guide

Fact sheet

Phase 0 - Human data before phase 1

Fact sheet

Extractables and leachables for inhalation products

Fact sheet

Recipharm Inhalation Solutions™

Fact sheet

Inhalation & nasal product manufacturing

Webinar

From mg to kg: first steps towards a scalable process for drug substances

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page ››
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2019 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå